TCGX Acquisition Corp.
Status: Live Deal
U=S
| IPO Proceeds, $M | $86.25M |
|---|---|
| IPO Date | Aug 5, 2026 |
| CEO | Chen Yu, M.D., M.B.A. |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | TriGemX Bio, Inc. |
| Deal Announced | Oct 19, 2026 |
| Deal Size, $M | $599.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | TBD |
TCGX
| Price | $12.32 |
|---|---|
| Last closing price | $12.26 |
| H/L, today | $9.90 / $12.27 |
| Volume, today | 1,793,900 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.